Skip to main content
. 2017 Jun 28;8(37):61944–61957. doi: 10.18632/oncotarget.18734

Table 1. Overview for the characteristics of the cohort.

Clinicopathologic features Case number Percentage
Age
 ≤55 ys 61 38.6%
 >55 ys 97 61.4%
Gender
 Female 53 33.5%
 Male 105 66.5%
Localization
 Upper 30 19.0%
 Middle 67 42.4%
 Lower 61 38.6%
Tumor size
 ≤5.0 cm 91 57.6%
 >5.0 cm 67 42.4%
Invasion depth
 T1-T2 54 34.2%
 T3-T4 104 65.8%
Differentiation
 Well 15 9.5%
 Modern 74 46.8%
 Poor 69 43.7%
TNM stage
 I-II 63 39.9%
 III-IV 95 60.1%
SRPK1 expression
  Low 75 47.5%
  High 83 52.5%